Viridian Therapeutics宣布根据纳斯达克上市规则5635（c）（4）提供奖励拨款

2025-10-03 04:11

Viridian Therapeutics (NASDAQ:VRDN) announced that its compensation committee has approved the grant of non-qualified stock options to purchase 147,650 shares of its common stock to four new employees.
The grants, made outside the company’s 2016 equity incentive plan, are part of an inducement for the employees to join the company.
Under Nasdaq Listing Rule 5635(c)(4), the options have an exercise price equal to the closing price of Viridian's stock on the grant date, October 1, 2025.
The options will vest over a four-year period, with 25% vesting on the one-year anniversary of the employees' start date and the remainder vesting in equal monthly installments, contingent on continued employment.
VRDN +0.14% after hours to $21.23.
Source: Press Release

More on Viridian Therapeutics